Hepatology and Pancreatic Science

Department of Chronic Disease Epidemiology, Medical University of Lodz, 92-213 Lodz, Poland

Publications

• Mini Review   
  Exploring Novel Antiviral Therapies: Advances in Hepatitis C Treatment
  Author(s): Maria Loris*
  
  Hepatitis C Virus (HCV) infection is a major global health concern, with significant morbidity and mortality associated with chronic liver disease. While the advent of Direct-Acting Antiviral agents (DAAs) has revolutionized HCV treatment, challenges such as viral resistance and access to therapy persist. In this article, we review recent advancements in hepatitis C treatment, focusing on novel antiviral therapies that offer promise for further improving patient outcomes. We explore host-targeted therapies, combination regimens, therapeutic vaccines, and immune modulators as innovative approaches to enhance viral clearance and reduce liver-related complications. Additionally, we discuss challenges such as access to treatment, management of comorbidities, and global elimination efforts. By embracing these novel antiviral strategies and addressing existing barrie.. Read More»
  DOI: 10.37421/2573-4563.2024.8.282

  Abstract HTML PDF